The expert testimony of an oral surgeon should have been allowed in a product liability suit brought by a patient who contends her use of the drug Zometa led to the destruction of bone in her jaw, a federal appeals court has ruled, reversing a lower court’s decision and remanding the case.
The U.S. Court of Appeals for the Ninth Circuit ruled on April 4 that Senior District Judge Susan Illston of the U.S. District Court for the Northern District of California abused her discretion by excluding the testimony of Dr. Richard Jackson, an experienced oral and maxillofacial surgeon. Read the Ninth Circuit opinion here.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
